MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹18 Cr | ₹9.76 Cr | ₹6.66 Cr | ₹2.64 Cr | ₹0.93 Cr |
What is the latest Contingent Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹9.76 Cr |
| Mar2023 | ₹6.66 Cr |
| Mar2022 | ₹2.64 Cr |
| Mar2021 | ₹0.93 Cr |
How is Contingent Liabilities of MOREPEN LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | 87.61 | |
| Mar2024 | ₹9.76 Cr | 46.52 | |
| Mar2023 | ₹6.66 Cr | 152.33 | |
| Mar2022 | ₹2.64 Cr | 184.90 | |
| Mar2021 | ₹0.93 Cr | - | |
Compare Contingent Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹3,114.8 Cr | -7.4% | 14.7% | -7.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -7.4% |
14.7% |
-7.2% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses